Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Todd A. Katz"'
Publikováno v:
Journal of Ophthalmology, Vol 2018 (2018)
Purpose. To report the impact of baseline central retinal thickness (CRT) on outcomes in patients with diabetic macular edema (DME) in VIVID-DME and VISTA-DME. Methods. Post hoc analyses of two randomized controlled trials in which 862 DME patients w
Externí odkaz:
https://doaj.org/article/49f10e630ebc4907adbab54e4c2a2b2a
Autor:
Todd A. Katz, Anat Loewenstein, Chengxing Lu, Giovanni Staurenghi, Dilsher S. Dhoot, Jennifer J. Arnold, Jean-François Korobelnik
Publikováno v:
Ophthalmology Retina
Ophthalmology Retina, Elsevier, 2019, 3 (8), pp.663-669. ⟨10.1016/j.oret.2019.03.015⟩
Ophthalmology Retina, Elsevier, 2019, 3 (8), pp.663-669. ⟨10.1016/j.oret.2019.03.015⟩
PURPOSE: To evaluate the effect of baseline subretinal fluid (SRF) on treatment outcomes with intravitreal aflibercept injection (IAI) versus laser treatment in patients with diabetic macular edema (DME) in the VIVID and VISTA studies. DESIGN: Post h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07dbd8da91ba921790319091a800b244
https://doi.org/10.1016/j.oret.2019.03.015
https://doi.org/10.1016/j.oret.2019.03.015
Publikováno v:
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 56(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a215e67b071e2a97595aa9b0a7dd1360
https://pubmed.ncbi.nlm.nih.gov/33249110
https://pubmed.ncbi.nlm.nih.gov/33249110
Autor:
Jason S. Slakter, Salomon Y. Cohen, Alan F. Cruess, Paul Mitchell, Todd A. Katz, Christiane Ahlers, Paolo Lanzetta, Olaf Sowade, Oliver Zeitz
Publikováno v:
Acta Ophthalmologica. 96:e911-e918
Identify predictors for response to anti-vascular endothelial growth factor (VEGF) therapy in patients with neovascular (wet) age-related macular degeneration (nAMD).Retrospective, post hoc analysis of VIEW 1/2. Patients were randomized 1:1:1:1 to 0.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d69610fe04b84230cba625cd45c22d
https://doi.org/10.1111/aos.13751
https://doi.org/10.1111/aos.13751
Autor:
Frank G. Holz, Carola Metzig, Giovanni Staurenghi, Nicolas Feltgen, Jennifer J. Arnold, Chengxing Lu, Todd A. Katz
Publikováno v:
The British Journal of Ophthalmology
Background/aimsTo evaluate intravitreal aflibercept versus laser in subgroups of patients with baseline Diabetic Retinopathy Severity Scale (DRSS) scores ≤43, 47, and ≥53 in VIVID-DME and VISTA-DME.MethodsPatients with diabetic macular oedema wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075b06c512eaf1dc106bf9aa685c8a56
https://doi.org/10.1136/bjophthalmol-2017-310664
https://doi.org/10.1136/bjophthalmol-2017-310664
Autor:
Jean-François Korobelnik, Michael Larsen, Giovanni Staurenghi, David M. Brown, Oliver Zeitz, Todd A. Katz, David S. Boyer, Paul Mitchell, Alyson J. Berliner, Robert Vitti, Diana V. Do, Carola Metzig, Chengxing Lu, Frank G. Holz, Ian L. McAllister
Publikováno v:
Ophthalmology Retina
Ophthalmology Retina, Elsevier, 2018, 2 (10), pp.988-996. ⟨10.1016/j.oret.2018.02.011⟩
Ophthalmology Retina, Elsevier, 2018, 2 (10), pp.988-996. ⟨10.1016/j.oret.2018.02.011⟩
International audience; PURPOSE: To evaluate the impact of intravitreal aflibercept (EYLEA, Regeneron Pharmaceuticals, Tarrytown, NY) versus laser on progression of diabetic retinopathy (DR) severity in Intravitreal Aflibercept Injection in Vision Im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dcc4fbf3481c2601a6d47c94e9a9893
https://hal.archives-ouvertes.fr/hal-03164912/file/BPH_OR_2018_Mitchell.pdf
https://hal.archives-ouvertes.fr/hal-03164912/file/BPH_OR_2018_Mitchell.pdf
Publikováno v:
Journal of Ophthalmology
Journal of Ophthalmology, Vol 2018 (2018)
Journal of Ophthalmology, Vol 2018 (2018)
Purpose. To report the impact of baseline central retinal thickness (CRT) on outcomes in patients with diabetic macular edema (DME) in VIVID-DME and VISTA-DME. Methods. Post hoc analyses of two randomized controlled trials in which 862 DME patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552d17f263adc2e954c2516225c6f149
https://pubmed.ncbi.nlm.nih.gov/29785301
https://pubmed.ncbi.nlm.nih.gov/29785301
Autor:
Paul Mitchell, Ursula Schmidt-Erfurth, Glenn J. Jaffe, Christian Simader, Giovanni Staurenghi, N. Victor Chong, Todd A. Katz, Chengxing Lu, Sebastian M. Waldstein
Publikováno v:
Ophthalmology. 123(7)
Purpose To compare the efficacy of intravitreal aflibercept and ranibizumab on the exudative activity of neovascular age-related macular degeneration (nAMD) using optical coherence tomography (OCT) and to correlate morphologic findings with visual ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bbbb142a19cff58ba8884fd1952febc
https://pubmed.ncbi.nlm.nih.gov/27157149
https://pubmed.ncbi.nlm.nih.gov/27157149
Autor:
Jean-François Korobelnik, Sebastian Wolf, Francesco Bandello, Olaf Sowade, Todd A Katz, A. Loewenstein, Jason S. Slakter
Publikováno v:
Wolf, Sebastian; Bandello, Francesco; Loewenstein, Anat; Slakter, Jason; Katz, Todd; Sowade, Olaf; Korobelnik, Jean-Francois (2016). Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies. Ophthalmologica, 236(2), pp. 95-99. Karger 10.1159/000447725
Purpose: The aim was to describe baseline characteristics of the fellow eye of patients with neovascular age-related macular degeneration (nAMD). Methods: A pooled, post hoc analysis of patients with nAMD enrolled in the VIEW studies was carried out.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a6c18f15e6a022947cd210ccadacf9